Steris (STE) Misses Q1 EPS by 2c ; Offers Guidance
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $220.11 -1.99%
Revenue Growth %: +6.8%
Financial Fact:
Total revenues: 489.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +6.8%
Financial Fact:
Total revenues: 489.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q1 EPS of $2.83, $0.02 worse than the analyst estimate of $2.85. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.59 billion.
GUIDANCE:
Steris sees FY2026 EPS of $11.10-$11.30, versus the consensus of $10.20.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- Tarsus Pharmaceuticals (TARS) PT Raised to $105 at Jefferies
- Jefferies on MP Materials (MP): 'Magnet Ramp Remains on Track'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
